I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.

Leave site
Roche and Genentech at

ASN 2026

We will be contributing to topics related to
-
02:00 PM
Duration 120mins Denver, USA
INShore Phase III Study of Obinutuzumab vs MMF in Childhood-Onset Idiopathic Nephrotic Syndrome: Post Hoc Analysis Assessing the Impact of Prior Rituximab Use
Larry A. Greenbaum, Julien Hogan, Kenneth Lieberman, Kandai Nozu, Małgorzata Mizerska-Wasiak, Clotilde Druck Garcia, Andrea Angeletti, Jie Ding, Xiaoyan Han, Sijing Li, Franz Schaefer, Patricia Lehane
05:30 PM
Duration 15mins Denver, USA
Sefaxersen, a Novel mRNA-targeted Therapy for IgA Nephropathy: Interim Analysis of the Phase 3 IMAgINATION Trial
Jonathan Barratt, Jürgen Floege, Irene Noronha, Dana V. Rizk, Hong Zhang, Xiaonong Chen, Dominique Chauveau, Dong Ki Kim, Pedro Augusto Macedo de Souza, Ji (Emmy) Cheng, Vishal Duggal, Nelson Guerreiro, Jeannette Lo, Nadine E. Schmit, Yixuan Zou, Sean Barbour
02:00 PM
Duration 120mins Denver, USA
Obinutuzumab Facilitates Tubular Repair in Lupus Nephritis Independently of Histologic or Clinical Response: Post Hoc Analyses of Urine EGF in the Phase III REGENCY Trial
Brad H. Rovin, Holly J. Clarke, Juan M. Mejia-Vilet, Ben Lanza, Peiqing Yu, Theodore A. Omachi, William F. Pendergraft III, Harini Raghu
10:30 PM
Duration 10mins Denver, USA
Efficacy and Safety of Obinutuzumab in Adolescents with Active Lupus Nephritis: Primary Results From POSTERITY, a Phase II Global Trial
Marina Vivarelli, Deborah M. Levy, Gabriel Vega Cornejo, Maria Teresa Terreri, Aleksandra Zurowska, Adolfina Elizabeth Zuta Santillán, Katharine Moore, Joan Calzada-Hernández, Julien Hogan, Sandra Enciso-Peláez, Agustín Remesal Camba, Louise Oni, Peiqing Yu, Felix Erblang, Olga Mitrofanova, William Pendergraft, Patricia Lehane
Coming soon